217 related articles for article (PubMed ID: 22277251)
41. SLC39A7 upregulation links to skin fibrosis in systemic sclerosis via TGF-β/SMAD pathway.
Wen X; Aoi J; Mijee T; Kajihara I; Makino K; Fukushima S
J Dermatol; 2024 Jun; 51(6):863-868. PubMed ID: 38217370
[TBL] [Abstract][Full Text] [Related]
42. Establishment and characterization of scleroderma fibroblast clonal cell lines by introduction of the hTERT gene.
Kapanadze B; Morris E; Smith E; Trojanowska M
J Cell Mol Med; 2010 May; 14(5):1156-65. PubMed ID: 19432820
[TBL] [Abstract][Full Text] [Related]
43. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of transforming growth factor beta 1/activin receptor-like kinase 1 pathway gene expression by herbal compound 861 is related to deactivation of LX-2 cells.
Li L; Zhao XY; Wang BE
World J Gastroenterol; 2008 May; 14(18):2894-9. PubMed ID: 18473417
[TBL] [Abstract][Full Text] [Related]
45. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1.
Holmes A; Abraham DJ; Chen Y; Denton C; Shi-wen X; Black CM; Leask A
J Biol Chem; 2003 Oct; 278(43):41728-33. PubMed ID: 12888575
[TBL] [Abstract][Full Text] [Related]
46. The expression profile of the toll-like receptor family in scleroderma dermal fibroblasts.
Sakoguchi A; Nakayama W; Jinnin M; Wang Z; Yamane K; Aoi J; Makino K; Kajihara I; Ichihara A; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-4-9. PubMed ID: 24959869
[TBL] [Abstract][Full Text] [Related]
47. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
Wang Z; Jinnin M; Nakamura K; Harada M; Kudo H; Nakayama W; Inoue K; Nakashima T; Honda N; Fukushima S; Ihn H
Exp Dermatol; 2016 Feb; 25(2):131-6. PubMed ID: 26566700
[TBL] [Abstract][Full Text] [Related]
49. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
[TBL] [Abstract][Full Text] [Related]
50. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
Kubo M; Ihn H; Yamane K; Tamaki K
J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152
[TBL] [Abstract][Full Text] [Related]
51. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.
Hong KH; Yoo SA; Kang SS; Choi JJ; Kim WU; Cho CS
Clin Exp Immunol; 2006 Nov; 146(2):362-70. PubMed ID: 17034590
[TBL] [Abstract][Full Text] [Related]
52. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.
Makino K; Makino T; Stawski L; Mantero JC; Lafyatis R; Simms R; Trojanowska M
J Invest Dermatol; 2017 Aug; 137(8):1671-1681. PubMed ID: 28433542
[TBL] [Abstract][Full Text] [Related]
53. Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts.
Yi SL; Liu XJ; Zhong JQ; Zhang Y
PLoS One; 2014; 9(1):e85144. PubMed ID: 24454806
[TBL] [Abstract][Full Text] [Related]
54. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
56. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
57. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
[TBL] [Abstract][Full Text] [Related]
58. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
59. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
60. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.
Dees C; Tomcik M; Palumbo-Zerr K; Distler A; Beyer C; Lang V; Horn A; Zerr P; Zwerina J; Gelse K; Distler O; Schett G; Distler JH
Arthritis Rheum; 2012 Sep; 64(9):3006-15. PubMed ID: 22549363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
